LH:NYSE
LabCorp
US$ 372,23
arrow_upward
+0,36%(+1,35) 1D
US$ 372,23
0,00% (0,00)
bedtimeNa sluitingstijd
Gesloten: 11 nov, 16:00:02 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor LH genereren…
Openen
US$ 369,33
Hoog
US$ 372,49
Laag
US$ 367,33
Beursw.
30,23 mld.
Gem. vol.
731,35K
Volume
741,77K
Dividend
0,77%
Kwartaaldividend
US$ 0,72
Ex-dividenddatum
29 mei 2026
Koers/winst-verhouding
30,53
52 wk hoog
US$ 373,76
52 wk laag
US$ 245,00
WPA
US$ 12,19
Bèta
0,87
Uitstaande aandelen
81,20 mln.
Aantal medewerkers
71K
Openen
US$ 369,33
Hoog
US$ 372,49
Laag
US$ 367,33
Beursw.
30,23 mld.
Gem. vol.
731,35K
Volume
741,77K
Dividend
0,77%
Kwartaaldividend
US$ 0,72
Ex-dividenddatum
29 mei 2026
Koers/winst-verhouding
30,53
52 wk hoog
US$ 373,76
52 wk laag
US$ 245,00
WPA
US$ 12,19
Bèta
0,87
Uitstaande aandelen
81,20 mln.
Aantal medewerkers
71K
Nieuwsartikelen
Van webbronnen en nieuwspartners
HealthExec
·
1 dag geleden
Labcorp buys specialty drug testing lab company for $375M
Zacks
·
1 dag geleden
Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?
Profiel
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Over LabCorp
CEOAdam H. Schechter
Medewerkers71K
Opgericht1978
HoofdkantoorBurlington, North Carolina, Verenigde Staten
SectorHealth Care
Industrie-
Websitelabcorp.com